These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8647949)

  • 21. Modulation by nitric oxide of prostaglandin biosynthesis in the rat.
    Sautebin L; Ialenti A; Ianaro A; Di Rosa M
    Br J Pharmacol; 1995 Jan; 114(2):323-8. PubMed ID: 7533614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H; Fret HR; Herman AG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
    Berenger-Bahuet FP; Rolland PH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
    Ng SS; Pang CC
    Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
    Pieper GM; Clarke GA; Gross GJ
    J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide stimulates the phosphorylation of rap1b in human platelets and acts synergistically with iloprost.
    Reep BR; Lapetina EG
    Biochem Biophys Res Commun; 1996 Feb; 219(1):1-5. PubMed ID: 8619788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium.
    Chen JX; Berry LC; Tanner M; Chang M; Myers RP; Meyrick B
    J Cell Physiol; 2001 Jan; 186(1):116-23. PubMed ID: 11147806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of a platelet component to endothelial prostacyclin production despite inhibition of platelet cyclooxygenase activity.
    Czervionke RL; Hoak JC; Haycraft DL; Fry GL; Mann KG
    Trans Assoc Am Physicians; 1982; 95():272-9. PubMed ID: 6820742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
    Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of nitric oxide and 6-keto-prostaglandin F(1alpha) production in bovine aortic endothelial cells by conjugated linoleic acid.
    Coen P; Cummins P; Birney Y; Devery R; Cahill P
    Endothelium; 2004; 11(3-4):211-20. PubMed ID: 15370299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide induces transient Ca2+ changes in endothelial cells independent of cGMP.
    Volk T; Mäding K; Hensel M; Kox WJ
    J Cell Physiol; 1997 Sep; 172(3):296-305. PubMed ID: 9284949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
    Starzyk D; Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1999 Dec; 50(4):629-37. PubMed ID: 10639013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types.
    Swierkosz TA; Mitchell JA; Tomlinson A; Botting RM; Warner TD; Vane JR
    Pol J Pharmacol; 1994; 46(6):587-92. PubMed ID: 7542521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiplatelet properties of nitrogen monoxide].
    Adrie C
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1527-32. PubMed ID: 9092414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide donors as generators and scavengers of superoxide anions.
    Robak J; Gryglewski RJ
    Pol J Pharmacol; 1993; 45(1):51-8. PubMed ID: 8401759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.